Spring Top 200 Final Flashcards
(51 cards)
atorvastatin
Lipitor, Caduet (combo product).
HMG-CoA Reductase Inhibitor.
Dyslipidemia.
BBW: N/A
omega-3-polyunsaturated fatty acids
Lovaza.
Antilipemic Agent, Omega-3 Fatty Acids.
Hypertriglyceridemia.
BBW: N/A
furosemide
Lasix.
Loop Diuretic.
Edema in HF, HTN, acute pulmonary edema
BBW: Fluid & Electrolyte Depletion
hydrochlorothiazide
Microzide.
Thiazide Diuretic.
HTN & edema
BBW: N/A
clonidine
Catapres, Catapres-TTS.
Alpha2 Agonist.
HTN
BBW: The 500 mcg/mL strength product should be diluted prior to use in an appropriate solution (injectable form).
metoprolol succinate
Toprol XL. BB.
Angina pectoris, HTN, or hemodynamically-stable acute MI.
BBW: Avoid abrupt cessation in ischemic heart disease
carvedilol
Coreg, Coreg CR.
BB with Alpha1-Blocking Activity
Indication: Mild-to-severe heart failure
BBW: N/A
amlodipine
Norvasc, Caduet (combo product), Lotrel (combo product).
CCB (Dihydropyridine).
HTN, angina.
BBW: N/A
diltiazem
Cardizem CD, Cardizem SR, Cartia XT.
CCB (Nondihydropyridine).
HTN, angina.
BBW: N/A
lisinopril
Zestril, Prinivil.
ACEI.
HTN, HF, MI.
BBW: fetal toxicity
digoxin
Digitek, Lanolin.
Antiarrhythmic, Cardiac Glycoside.
Afib & HF.
BBW: N/A
isosorbide dinitrate
Isordil.
Antianginal agent.
Angina prevention.
BBW: N/A
warfarin
Coumadin.
Vit K Antagonist.
Ppx and tx of thromboembolic disorders arising from afib/cardiac valve replacement; reduce risk of systemic embolism.
BBW: Bleeding risk
clopidogrel
Plavix.
Anti platelet Agent.
Unstable angina; NSTEMI; STEMI; recent MI/stroke; established PAD.
BBW: Increased levels in poor metabolizers (CYP 2C19)
enoxaparin
Lovenox.
LMWH.
Ppx and tx of DVT, unstable angina, NSTEMI, & STEMI.
BBW: Spinal/epidural hematomas
dabigatran
Pradaxa.
Thrombin Inhibitor.
Ppx of stroke & systemic embolism in patients with nonvalvular afib.
BBW: Discontinuing early inc risk of thrombotic event; spinal/epidural hematoma
rivaroxaban
Xarelto.
Factor Xa inhibitor.
Ppx of DVT in pts undergoing hip/knee replacement; prevention of stroke & systemic embolism in patients with nonvalvular afib; tx of acute PE & DVT without PE.
BBW: Discontinuing early inc risk of thrombotic event; spinal/epidural hematomas
amiodarone
Cordarone, Pacerone.
Antiarrhythmic Agent, Class III.
Ventricular arrythmias (vtach, vfib).
BBW: only for life-threatening arrhythmias, fatal toxicities, patients at high risk arrhythmic death
dofetilide
Tikosyn
Antiarrhythmic Agent, Class III
Mx of NSR in pts with chronic afib/a-flutter of longer than 1-week duration who have been converted to NSR; conversion of afib & a-flutter to NSR
BBW: should be placed for a minimum of 3 days in a facility that can provide calc of CrCl, continuous EKG monitoring, & cardiac resuscitation
alteplase
Activase.
Tissue plasminogen activator; fibrinolytic.
PE, STEMI, acute ischemic stroke.
BBW: N/A
calcium acetate
Phoslo.
Phosphate Binder.
Hyperphosphatemia in ESRD
BBW: N/A
sevelamer
Renagel, Renvela.
Phosphate Binder.
Hyperphosphatemia in pts with CKD on hemodialysis
BBW: N/A
midodrine
None.
α1 agonist.
Orthostatic hypotension.
BBW: can cause significant elevation of supine blood pressure, so only to be used in pts whose lives are considerably impaired despite std clinical care. Clinical benefits have not been verified
epoetin alfa
Procrit, Epogen.
Colony Stimulating Factor; Erythropoiesis Stimulating Agent.
Anemia
BBW: inc CV events, tumor progression in cancer